Inhaled medicines and biological therapies in the current era of systemic treatments

Hot topic
Chairs: O. Usmani (London, United Kingdom), I. Adcock (London, United Kingdom), T. Maes (Ghent, Belgium)
Aims: to explore the recent rapid advances in innovative inhaled biological therapies and their clinical translation; to consider solutions to problems that are impeding the translation of basic science findings into clinically useful treatments.

Understanding the behaviours of inhaled biologicals at the airway epithelium N. Heuzé-Vourc'h (Tours, France)
Inhaled antibodies: targeting tumour necrosis factor receptor 1 and thymic stromal lymphopoietin C. Summers (Cambridge (Cambridgeshire), United Kingdom)
Inhaled and small molecules therapeutics to fight respiratory syncytial virus infection in newborn lung M. Ackermann (Corvallis, United States of America)
Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future? G. Anderson (Parkville (VIC), Australia)